Neurological Signs of Postcovid Syndrome.

Area of Science:

• Neurology
• Infectious Diseases
• Pharmacology

Background:

• Post-COVID syndrome (PCS) is a significant global health concern.
• PCS exhibits a wide range of clinical manifestations, particularly neurological symptoms.
• Understanding the underlying mechanisms of PCS is crucial for effective management.

Purpose of the Study:

• To discuss the primary neurological signs associated with Post-COVID syndrome.
• To present data on the presumed mechanisms contributing to the development of PCS.
• To evaluate the therapeutic potential of Mexidol in managing PCS patients.

Main Methods:

• Literature review of neurological manifestations in Post-COVID syndrome.
• Analysis of existing data on the pathogenetic mechanisms of PCS.
• Review of studies investigating Mexidol's efficacy in neurological disorders.

Main Results:

• Detailed description of common neurological symptoms observed in PCS.
• Presentation of hypotheses regarding the formation of PCS, including neuroinflammation and autoimmune responses.
• Preliminary data suggesting Mexidol's potential benefits in mitigating neurological deficits in PCS.

Conclusions:

• Post-COVID syndrome poses a complex neurological challenge.
• Further research is warranted to elucidate PCS pathogenesis.
• Mexidol shows promise as a potential therapeutic agent for neurological complications of PCS.